EP PerMed Research Innovation and Technology Call (RITC) 2026
The European Partnership for Personalised Medicine, EP PerMed supported by the European Union under Horizon Europe, Grant Agreement N° 101137129, has launched its first research, innovation and technology call (RITC2026) for proposals on “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine”, acronym “MultiPMData2026”. In total, 19 funding organisations participate in this call with an available budget of over 14.8 Mio. € (approx.).
EP PerMed funding organisations, listed below, have agreed to jointly fund multinational innovative research and technology projects in personalised medicine (PM) to encourage innovative, interdisciplinary public-private partnerships and to support the translational and clinical implementation of research outcomes.
The call will be implemented in two stages: a pre and a full proposal phase.
Expected timeline of the call
- 1 October 2025: Publication of the call
- 28 October 2025: RITC2026 Information Day – online webinar
- 18 November 2025: RITC2026 Matchmaking Event – online event
- 12 January 2026 (14:00, CET): Deadline for pre-proposal submission
- Expected around 19 March 2026: Communication of the results of the pre-proposal assessment and invitation to the full proposal stage
- 27 April 2026 (14:00, CEST): Deadline for full-proposal submission
- End of June 2026: Rebuttal stage
- Expected for beginning of September 2026: Communication of the funding decisions to the applicants
- End of 2026, beginning of 2027: 6-months starting phase (development of Consortium Agreement, Data Management Plan and Ethics Approvals).
Expected scientific project start. Establishment of funding contracts with funding organisations (according to regional/national funding regulations).